Paschol en es it fr

Paschol Brand names, Paschol Analogs

Paschol Brand Names Mixture

  • No information avaliable

Paschol Chemical_Formula

C24H36O5

Paschol RX_link

http://www.rxlist.com/cgi/generic3/altocor.htm

Paschol fda sheet

Paschol FDA

Paschol msds (material safety sheet)

Paschol Synthesis Reference

R. L. Monaghan et al., U.S. Pat. 4,231,938 (1980)

Paschol Molecular Weight

404.54 g/mol

Paschol Melting Point

174.5 oC

Paschol H2O Solubility

0.0004 mg/mL

Paschol State

Solid

Paschol LogP

4

Paschol Dosage Forms

Tablet

Paschol Indication

For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia; For primary prevention of coronary heart disease

Paschol Pharmacology

Lovastatin, an antilipemic agent produced by fermentation of Aspergillus terreus, is the first of a class of lipid-lowering agents known as the HMG-CoA reductase inhibitors. Lovastatin is used to treat hypercholesterolemia, to slow coronary atherosclerosis, and to prevent myocardial infarction and stroke. Lovastatin, like simvastin and unlike pravastatin, is a prodrug, concentrating active drug in the liver during first-pass circulation.

Paschol Absorption

30%

Paschol side effects and Toxicity

LD50>1000 mg/kg (orally in mice)

Paschol Patient Information

PATIENT INFORMATION

Lovastatin is used to lower high cholesterol levels. This medication should
not be taken if you are pregnant, nursing, or have liver disease. Lovastatin
should be taken with the evening meal. This medication may cause increased
sensitivity to sunlight. Use sunscreens and wear protective clothing until
degree of sensitivity is determined. Notify your physician if you develop
blurred vision; skin rash; muscle pain, weakness, or cramps; unexplained fever,
or yellowing of the skin or eyes.

Patients should be advised about substances they should not take concomitantly
with lovastatin and be advised to report promptly unexplained muscle pain,
tenderness, or weakness (see list below and WARNINGS, Myopathy/Rhabdomyolysis ).
Patients should also be advised to inform other physicians prescribing a new
medication that they are taking MEVACOR .

Paschol Organisms Affected

Humans and other mammals